Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. (Q38212451)
Jump to navigation
Jump to search
scientific article published on 18 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. |
scientific article published on 18 April 2014 |
Statements
Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis (English)
Zheng Wang
Song-Tao Lai
Li Xie
Jian-Dong Zhao
Ning-Yi Ma
Zhi-Gang Ren
Guo-Liang Jiang